Although the lymph node lymphatic vessel growth and development is positively regulated by B cells and macrophages, Kataru et al. (2011) , in this issue of Immunity, show negative regulation of lymphatic vessels by interferon-g from T cells.
Lymph nodes (LNs) can act as immunological filters that are strategically situated throughout the mammalian body to trap particles or antigens from peripheral tissue. LNs maintain active homeostasis in size and content at steady state. However, their size changes dramatically in response to changes in the local environment such as infection, cancer, and vaccination. These conditions lead to enlarged LNs followed by regression after the resolution of inflammation. Remodeling of lymphatic vessels (LVs) and blood vessels (BV) are thought to be a key step in controlling these changes. Which cells, membrane or soluble cytokines, are essential for lymphatic vessel homeostasis and dynamic changes in expansion and regression phases have not been well defined. Recent studies have reported that peripheral inflammation transiently induces robust lymphangiogenesis in draining LNs (Halin et al., 2007; Kataru et al., 2009; Liao and Ruddle, 2006) . Vascular endothelial growth factors (VEGFs) are thought to mediate most of this LN lymphangiogenesis, and VEGF-A, -C, and -D are increased at the site of inflammation (Halin et al., 2007; Kataru et al., 2009) . Various intranodal cellular components, such as B cells, stromal fibroblastic reticular cells, and macrophages, are also involved in the process of inflammatory LN lymphangiogenesis by secreting VEGFs (Angeli et al., 2006; Chyou et al., 2008; Kim et al., 2009 Interferon-g (IFN-g) is well known for its antiangiogenic effect (Ruegg et al., 1998) . Kataru et al. (2011) hypothesized that T cell-derived IFN-g is the LNLV-inhibitory factor. Indeed, IFN-g treatment markedly reduced LNLV density. Furthermore, adoptive transfer of T cells from IFN-gdeficient mice could not suppress the increased LNLV density in athymic mice. However, it is noteworthy that LNLV suppression still occurred in areas where IFN-g-deficient T cells were heavily populated. These results together suggest that IFN-g from T cells is a potent factor for LNLV suppression, but whether this is a direct or indirect role on the lymphatic vessels is less clear. Because very few T cells in the LNs of naive WT mice produce IFN-g, it is intriguing that so few IFN-g-producing T cells would have such a profound effect on LNLV suppression. Therefore, the T cell density and proximity to LNLV might be important.
Kataru et al. (2011) Although these results support a direct role of T cell-derived IFN-g on LNLV inhibition, it is still unclear whether stromal fibroblastic reticular cells and their VEGF production are involved (Chyou et al., 2008) . Conditional deletion of IFN-g receptor in the various cells would help to distinguish whether LNLV or fibroblastic reticular cells is the target. The authors further designed a series of in vitro experiments demonstrating a direct inhibition of IFN-g on LNLV endothelial cell (LEC) growth. Prox-1, the master transcriptional factor of LECs, was markedly but not completely inhibited by T cell-derived IFN-g on primary cultured LECs in vitro through the JAK1-STAT1 signaling pathway. This result suggests the presence of other T cell-derived factors on LNLV negative regulation.
What is the biological significance and implications of this work? LNLVs are used as conduits to facilitate the physical interaction between antigen-carrying DCs and their corresponding T cells (von Andrian and Mempel, 2003 ). An intriguing result of this study is that the elevated LV density in T cell-deficient instead of B cell-deficient LNs is associated with the increased recruitment of antigen-carrying DCs into the LNs. The biological function of LNLV regression for immune cell retention or exit is currently unknown. This IFN-g-mediated LNLV suppression might also help to prevent excessive immune responses, which might be immunopathogenic, leading to autoimmunity or inhibiting memory T cell generation. In addition, are T cells and IFN-g unique in this setting? NK cells migrate into LNs during early inflammation and they also produce IFN-g (Martin-Fontecha et al., 2004) . Could NK cell-derived IFN-g also induce LNLV regression even before T cells? Although other sources of IFN-g in the LNs are present early in the response, it could be that the LNLV does not regress because the corresponding positive signals that increase LN size are dominant at the initiation phase of the immune response. At late stages, however, the positive signals may subside, allowing for negative regulation of the LNLV by antigen-expended T cells to be dominant.
IFN-g production from antigen-reactive T cells might indicate a well-developed T helper 1 (Th1) cell response, which is important for viral clearance, but too much IFN-g could be detrimental to the body. From an evolutionary point of view, the host wants an optimal amount of IFN-g in response to antigens or inflammation. If, for example, T cells are disregulated and produce too much IFN-g, this negative-feedback mechanism controlling LNLV regression could be initiated to control the extent of inflammation-and/or antigen-specific immune responses. The current study reveals a role of T cell-derived IFN-g on LNLV inhibition and raises many interesting questions. In addition to IFN-g, can other cytokines play a similar role? Do IL4, IL-17, and IL-22 from other subset of T cells have similar function on LNLV? Does this effect on LNLV also apply to LN high endothelial venule (HEV) cells as well? Because HEV is the critical site where T cells migrate into LN, a negative-feedback mechanism on HEV itself would be more efficient. In addition, can effector Th1 cells control peripheral tissue vessels during their effector phase? This would be also helpful for the resolution of peripheral tissue inflammation.
LN homeostasis and remodeling is a dynamic progress involving different cellular components at various times and locations and host environmental conditions. Although B cells and some innate cells are critical for LN remodeling at the early stage of inflammation, T cells have now been found to be a critical negativefeedback regulator at the resolving stage (Figure 1 ). It is intriguing how this kinetic regulation occurs. One can speculate that B cells and innate cells can be activated in a nonantigen-specific way by danger signals and thus respond earlier during inflammation to produce VEGF. In addition, B cell-derived lymphotoxin could stimulate stroma fibroblastic reticular cells for additional VEGF production. As for T cells, they have to undergo antigen-specific activation and differentiation for enough IFN-g production, which takes longer time and thus its function may display later. Perhaps an unknown negative regulation mechanism on VEGF production also exists to allow T cell-derived IFN-g to dominate at the later stage of inflammation. Kataru et al. (2011) have extended our understanding about this process and raised a series of stimulating questions to be addressed in the future. Tfh cells exhibit effector function (help for B cells), and like other T effectors, have downregulated CCR7. Despite this, they are disproportionately located in secondary lymphoid organs rather than inflamed nonlymphoid parenchyma, but specifically within follicles rather than T zones (Campbell et al., 2003) . This is due to loss of CCR7 and expression of CXCR5, the receptor for CXCL13, which is expressed constitutively by follicular stroma. CXCR5 is expressed by all mature B cells and by a small proportion of memory T cells, but the highest expression of CXCR5 is found on Tfh cells. Tfh cells secrete predominantly IL-21 and IL-4 and lesser amounts of IFN-g and IL-17 (Yu and Vinuesa, 2010) . To complicate matters further, there appears to be another population of T cells that is dependent on Bcl6, exhibits Tfh cell-like activity, but is located in extrafollicular plasma cell foci (Poholek et al., 2010 in blood also remains uncertain. These cells are absent from the blood in patients lacking ICOS, which suggests that they are related to Tfh cells (Bossaller et al., 2006) . This is also supported by their abundance in mouse models characterized by excessive Tfh cell production in secondary lymphoid tissues (Simpson et al., 2010) . 
